Evidence map›Paper›PMID 26511801›Full record

ArticleCancer research and treatment2016

Delay of Treatment Initiation Does Not Adversely Affect Survival Outcome in Breast Cancer.

Tae-Kyung Yoo, Wonshik Han, Hyeong-Gon Moon, Jisun Kim, Jun Woo Lee, Min Kyoon Kim, Eunshin Lee, Jongjin Kim, Dong-Young Noh

Abstract read
In one paragraph

Article in Cancer research and treatment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Patient and Care Delays of Breast Cancer in China.Cancer research and treatment · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tae-Kyung YooDepartment of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Wonshik HanDepartment of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Hyeong-Gon MoonDepartment of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Jisun KimDepartment of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Jun Woo LeeDepartment of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Min Kyoon KimDepartment of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Eunshin LeeDepartment of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Jongjin KimDepartment of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Dong-Young NohDepartment of Surgery, Seoul National University College of Medicine, Seoul, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePrevious studies examining the relationship between time to treatment and survival outcome in breast cancer have shown inconsistent results. The aim of this study was to analyze the overall impact of delay of treatment initiation on patient survival and to determine whether certain subgroups require more prompt initiation of treatment. MATERIALS AND

methodsThis study is a retrospective analysis of stage I-III patients who were treated in a single tertiary institution between 2005 and 2008. Kaplan-Meier survival analysis and Cox proportional hazards regression model were used to evaluate the impact of interval between diagnosis and treatment initiation in breast cancer and various subgroups.

resultsA total of 1,702 patients were included. Factors associated with longer delay of treatment initiation were diagnosis at another hospital, medical comorbidities, and procedures performed before admission for surgery. An interval between diagnosis and treatment initiation as a continuous variable or with a cutoff value of 15, 30, 45, and 60 days had no impact on disease-free survival (DFS). Subgroup analyses for hormone-responsiveness, triple-negative breast cancer, young age, clinical stage, and type of initial treatment showed no significant association between longer delay of treatment initiation and DFS.

conclusionOur results show that an interval between diagnosis and treatment initiation of 60 days or shorter does not appear to adversely affect DFS in breast cancer.

Indexed as

Time-to-TreatmentAdultAgedAged, 80 and overAge FactorsBiopsyBreastBreast NeoplasmsChemotherapy, AdjuvantDisease-Free SurvivalFemaleHumansKaplan-Meier EstimateLymphatic MetastasisMiddle AgedNeoplasm StagingBreast neoplasmsSurvival rateTime-to-treatment

Identifiers

PMID26511801
PMCPMC4946375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.